Approved indications
- Xyosted is FDA-approved for testosterone replacement therapy in adult men with primary (testicular) or hypogonadotropic (pituitary-hypothalamic) hypogonadism, when these conditions are confirmed by symptoms and consistently low serum testosterone levels.
- It is not approved for use in men with age-related ("late-onset") hypogonadism without clear pathologic causes, and not approved for use in women or children.

Off-label uses
- Clinicians may occasionally use injectable testosterone products off-label for other forms of androgen deficiency, but Xyosted specifically is generally restricted to its labeled hypogonadism indications because of its fixed-dose, once-weekly design.
- Evidence for broader uses (e.g., improving athletic performance, anti-aging, or non-specific fatigue) is limited and such uses are discouraged because of safety concerns.

Efficacy expectations
- Many patients begin to notice improvements in energy, libido, and mood within several weeks; full effects on sexual function, body composition, and bone density may take several months of stable, in-range testosterone levels.
- In clinical studies, a high proportion of men achieved average weekly testosterone levels within the target physiologic range with once-weekly injections.
- Compared with other testosterone formulations, Xyosted offers more stable testosterone levels over the dosing interval than some older intramuscular injections, and more predictable dosing than topical gels (which can vary with application and absorption), but overall symptom improvement is similar when testosterone levels are normalized.

Typical dosing and how to take
- Usual starting dose for adult men is 75 mg of testosterone enanthate injected subcutaneously once weekly using the prefilled autoinjector.
- Based on trough serum testosterone levels and clinical response, the dose is usually adjusted in 25 mg increments to 50 mg, 75 mg, or 100 mg once weekly.
- Injections are given under the skin of the abdomen (avoiding the navel area), rotating sites each week to reduce skin irritation.
- It can be administered with or without regard to meals; the key is consistent once-weekly timing as directed.

Special dosing instructions
- Dose selection and titration are guided by measured morning serum testosterone concentrations, generally at the end of a dosing interval (just before the next injection), along with symptom control and tolerability.
- Do not change the dose or stop therapy without consulting the prescriber; abrupt discontinuation can lead to return of low-testosterone symptoms.
- Autoinjectors are single-use only and must not be shared with anyone else.

Missed dose guidance
- If a weekly dose is missed and it is only been a short time since the scheduled day, administer the dose as soon as remembered and then resume the usual weekly schedule from that new day, according to prescriber advice.
- If it is close to the time of the next scheduled injection, skip the missed dose and take the next dose at the regular time; do not inject two doses at once to make up for a missed dose.
- For any uncertainty about timing after a missed dose, contact the prescriber or pharmacist for specific guidance.

Overdose
- Using more than prescribed or injecting doses too frequently can increase the risk of severe side effects such as very high blood pressure, blood clots, extreme mood changes, or marked erythrocytosis.
- In case of suspected overdose, do not take further doses and seek medical advice immediately; for worrisome symptoms such as chest pain, severe shortness of breath, or sudden neurological symptoms, seek emergency care.

Common side effects
- Common effects include increased red blood cell count (erythrocytosis), acne or oily skin, injection-site bruising or pain, headache, mood changes, and increased blood pressure.
- Some men may notice fluid retention, mild weight gain, or breast tenderness/enlargement (gynecomastia).
- These effects often develop gradually over weeks to months and are usually mild to moderate, but they require periodic monitoring by the prescriber.

Serious or rare adverse effects
- Serious risks can include markedly increased blood pressure, cardiovascular events (such as heart attack or stroke), blood clots, significant erythrocytosis, liver dysfunction, worsening sleep apnea, and severe mood or behavior changes (aggression, irritability).
- Testosterone can worsen benign prostatic hyperplasia (BPH) symptoms and may accelerate growth of existing prostate cancer; it is contraindicated in known or suspected prostate or breast cancer in men.
- Seek immediate medical attention for chest pain, sudden shortness of breath, weakness on one side of the body, trouble speaking, vision changes, signs of blood clots (leg swelling or pain), or severe allergic reaction (swelling of face or throat, trouble breathing).

Warnings and precautions
- Not for use in women, especially if pregnant or breastfeeding, because of the risk of virilization of a fetus or nursing infant.
- Not recommended in children or adolescents; it can cause premature closure of growth plates and affect final height.
- Use with caution or may be inappropriate in men with significant cardiovascular disease, uncontrolled high blood pressure, severe sleep apnea, polycythemia, liver or kidney impairment, or a strong risk for prostate cancer (e.g., markedly elevated PSA, abnormal digital rectal exam).
- Periodic monitoring is typically needed: testosterone levels, hematocrit/hemoglobin, lipids, liver function, PSA and prostate assessments (in appropriate age groups), and blood pressure.

Safety compared with other options
- The general safety profile is similar to other testosterone products, with class-wide risks relating to cardiovascular events, erythrocytosis, prostate effects, and blood pressure elevations.
- Because Xyosted is a fixed-dose, once-weekly subcutaneous autoinjector, it reduces risk of dosing errors and transfer risk associated with topical gels, but it carries the same systemic testosterone-related risks and a specific emphasis on blood pressure increases.

Reporting side effects and staying updated
- Side effects should be reported promptly to the prescribing clinician or pharmacist.
- Patients in the United States can report adverse reactions directly to the FDA MedWatch program and can check the FDA website for the latest safety communications and label updates related to testosterone products.

Drug and supplement interactions
- Testosterone can enhance the effects of oral anticoagulants (such as warfarin), potentially increasing bleeding risk; closer INR monitoring and dose adjustments may be needed.
- It may reduce blood glucose levels and alter insulin or oral diabetes medication requirements; diabetic patients should monitor blood sugars closely when starting or changing dose.
- Concomitant use with corticosteroids or other drugs that cause fluid retention (e.g., some heart or kidney medications) can increase the risk of edema, especially in patients with heart, kidney, or liver disease.
- Androgen use may interact with certain thyroid hormone tests and other lab assays, potentially affecting interpretation of results.
- There are no major food restrictions, but limiting excess alcohol is advisable because alcohol can worsen liver problems, blood pressure, and cardiovascular risk.

Other precautions
- Contraindicated in men with known or suspected prostate cancer or male breast cancer, and in those with hypersensitivity to testosterone enanthate or product components.
- Use cautiously in men with severe benign prostatic hyperplasia, uncontrolled hypertension, serious cardiac, hepatic, or renal disease, or obstructive sleep apnea.
- Men with a history of blood clots, thrombophilia, or significant cardiovascular disease require careful risk–benefit assessment and close monitoring if therapy is used.

Monitoring needs
- Regular blood tests to monitor serum testosterone, hematocrit/hemoglobin, lipid profile, and liver function are typically recommended.
- Blood pressure should be checked before starting and periodically during treatment due to the risk of treatment-emergent hypertension or worsening pre-existing hypertension.
- For appropriate age groups or risk profiles, monitoring of prostate-specific antigen (PSA) and prostate exams are usually performed before initiation and periodically during therapy.
- Patients should inform all healthcare providers, including surgeons and emergency clinicians, that they are receiving testosterone therapy.

Q: What is Xyosted used for?
A: Xyosted is used as a once-weekly testosterone replacement injection for adult men who have confirmed low testosterone levels due to certain medical causes of hypogonadism, not simply due to normal aging.

Q: How long does it take for Xyosted to start working?
A: Some men notice improvements in energy, sex drive, or mood within a few weeks, but it can take several months of regular weekly injections and dose adjustments to see the full benefits on symptoms and lab values.

Q: Where do I inject Xyosted and can I do it myself?
A: Xyosted is injected under the skin of the abdomen using a prefilled autoinjector, and after proper training by a healthcare professional, most patients or their caregivers can administer it at home once a week.

Q: Do I need blood tests while on Xyosted?
A: Yes, regular blood tests are usually required to check testosterone levels, blood counts, lipids, liver function, and prostate-specific antigen (in appropriate age groups), and to help your prescriber adjust the dose and monitor safety.

Q: Is Xyosted safer than other forms of testosterone?
A: Xyosted has safety risks similar to other testosterone therapies, including effects on blood pressure, blood counts, the heart, and the prostate, but it avoids skin transfer issues seen with gels and offers more stable levels than some older injections when dosed correctly.

Q: Can I stop Xyosted suddenly if I feel better or worse?
A: You should not stop or change your dose without talking to your prescriber, because symptoms of low testosterone can return and your dose may need careful adjustment based on both how you feel and your lab results.

Storage

- Store Xyosted autoinjectors at room temperature (generally 20°C to 25°C / 68°F to 77°F), away from excess heat, moisture, and direct light.
- Keep in the original carton until use to protect from light and to keep the device clean and secure.
- Do not freeze; do not use if the solution is cloudy, discolored, or contains particles.

Handling and Disposal

- Use each prefilled autoinjector only once and do not attempt to reuse or recap it.
- Dispose of used autoinjectors right away in an FDA-cleared sharps disposal container; do not throw loose needles or devices in household trash or recycling.
- When the sharps container is about three-quarters full, follow local or state rules for disposal (pharmacy take-back, community collection sites, or as instructed by your healthcare provider or local waste authority).
- Keep all unused and used devices out of reach of children and pets.